May 20 |
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
May 16 |
Talphera to Participate at A.G.P. Virtual Healthcare Conference
|
May 14 |
Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript
|
May 14 |
AcelRx Pharmaceuticals GAAP EPS of -$0.16 beats by $0.06
|
May 14 |
Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update
|
May 13 |
AcelRx Pharmaceuticals Q1 2024 Earnings Preview
|
May 2 |
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
|
Mar 7 |
Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript
|
Mar 6 |
AcelRx Pharmaceuticals GAAP EPS of -$0.25, revenue of $0.3M
|
Mar 6 |
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
|